Dataset Information


NANOG Restores Contractility of Mesenchymal Stem Cell-Based Senescent Microtissues.

ABSTRACT: Mesenchymal stem cells (MSCs) have been extensively used in the field of tissue engineering as a source of smooth muscle cells (SMCs). However, recent studies showed deficits in the contractile function of SMCs derived from senescent MSCs and there are no available strategies to restore the contractile function that is impaired due to cellular or organismal senescence. In this study, we developed a tetracycline-regulatable system and employed micropost tissue arrays to evaluate the effects of the embryonic transcription factor, NANOG, on the contractility of senescent MSCs. Using this system, we show that expression of NANOG fortified the actin cytoskeleton and restored contractile function that was impaired in senescent MSCs. NANOG increased the expression of smooth muscle ?-actin (ACTA2) as well as the contractile force generated by cells in three-dimensional microtissues. Interestingly, NANOG worked together with transforming growth factor-beta1 to further enhance the contractility of senescent microtissues. The effect of NANOG on contractile function was sustained for about 10 days after termination of its expression. Our results show that NANOG could reverse the effects of stem cell senescence and restore the myogenic differentiation potential of senescent MSCs. These findings may enable development of novel strategies to restore the function of senescent cardiovascular and other SMC-containing tissues.


PROVIDER: S-EPMC5467120 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3508087 | BioStudies
2020-01-01 | S-EPMC6983709 | BioStudies
1000-01-01 | S-EPMC4922542 | BioStudies
2019-01-01 | S-EPMC6834418 | BioStudies
2017-01-01 | S-EPMC5397648 | BioStudies
2015-01-01 | S-EPMC4626238 | BioStudies
1000-01-01 | S-EPMC4394877 | BioStudies
2011-01-01 | S-EPMC3375237 | BioStudies
1000-01-01 | S-EPMC6158816 | BioStudies
2019-01-01 | S-EPMC6834426 | BioStudies